XML 23 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENT OF EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Accumulated Other Comprehensive Loss
Total Equity Attributable to Meritor, Inc.
Total Equity Attributable to Meritor, Inc.
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests
Beginning balance at Sep. 30, 2020 $ 495   $ 105 $ 808   $ 736   $ (573) $ (614) $ 462   $ 33
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Comprehensive income (loss) 138         95     39 134   4
Repurchase of convertible notes (30)     (30)           (30)    
Equity based compensation expense 10     10           10    
Vesting of equity based awards 0   1 (1)                
Noncontrolling interest dividends (1)                     (1)
Other equity adjustments 1     1           1    
Ending Balance at Mar. 31, 2021 613   106 788   831   (573) (575) 577   36
Beginning balance at Sep. 30, 2020 495   105 808   736   (573) (614) 462   33
Ending Balance at Sep. 30, 2021 $ 615 $ (23) 105 798 $ (40) 935 $ 17 (632) (632) 574 $ (23) 41
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06                      
Beginning balance at Dec. 31, 2020 $ 565   106 784   768   (573) (555) 530   35
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Comprehensive income (loss) 45         63     (20) 43   2
Equity based compensation expense 4     4           4    
Noncontrolling interest dividends (1)                     (1)
Ending Balance at Mar. 31, 2021 613   106 788   831   (573) (575) 577   36
Beginning balance at Sep. 30, 2021 615 $ (23) 105 798 $ (40) 935 $ 17 (632) (632) 574 $ (23) 41
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Comprehensive income (loss) 127         116     4 120   7
Equity based compensation expense 8     8           8    
Vesting of equity based awards 0   1 (1)                
Noncontrolling interest dividends (7)                     (7)
Ending Balance at Mar. 31, 2022 720   106 765   1,068   (632) (628) 679   41
Beginning balance at Dec. 31, 2021 638   106 761   1,006   (632) (644) 597   41
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Comprehensive income (loss) 81         62     16 78   3
Equity based compensation expense 4     4           4    
Noncontrolling interest dividends (3)                     (3)
Ending Balance at Mar. 31, 2022 $ 720   $ 106 $ 765   $ 1,068   $ (632) $ (628) $ 679   $ 41